WITHDRAWN: MiR-29a Inhibits Growth and Metastasis of Melanoma A375 Cells by Directly Targeting Bmi1

Ying Xiong, Liqian Liu, Ying Qiu, Lili Liu

Open source

DOI
10.3727/096504017x15061926356644
Published
2017
Container
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Publisher
Tech Science Press
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3727/096504017x15061926356644,
  title = {WITHDRAWN: MiR-29a Inhibits Growth and Metastasis of Melanoma A375 Cells by Directly Targeting Bmi1},
  author = {Ying Xiong and Liqian Liu and Ying Qiu and Lili Liu},
  year = {2017},
  journal = {Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics},
  doi = {10.3727/096504017x15061926356644},
  url = {https://doi.org/10.3727/096504017x15061926356644}
}

RIS

TY  - JOUR
TI  - WITHDRAWN: MiR-29a Inhibits Growth and Metastasis of Melanoma A375 Cells by Directly Targeting Bmi1
AU  - Ying Xiong
AU  - Liqian Liu
AU  - Ying Qiu
AU  - Lili Liu
PY  - 2017
JO  - Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
DO  - 10.3727/096504017x15061926356644
UR  - https://doi.org/10.3727/096504017x15061926356644
ER  - 

APA

Xiong, Y., Liu, L., Qiu, Y., & Liu, L. (2017). WITHDRAWN: MiR-29a Inhibits Growth and Metastasis of Melanoma A375 Cells by Directly Targeting Bmi1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. https://doi.org/10.3727/096504017x15061926356644

Source records